Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Smoking interferes with neurocognitive recovery during abstinence from alcohol

  • Stress-related inflammation may increase risk for depression

  • Biochemical cause of seasonal depression (SAD) confirmed by researchers

  • Key factor in transition from moderate to problem drinking

  • Immune proteins moonlight to regulate brain-cell connections

  • Fight against Alzheimer's disease: New research on walnuts

  • Why your brain makes you reach for junk food

  • See-through sensors open new window into the brain

  • New test to help brain injury victims recover

  • Fish intake associated with boost to antidepressant response

  •